(NASDAQ: DXCM) Dexcom's forecast annual revenue growth rate of 12.14% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.52%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.65%.
Dexcom's revenue in 2025 is $4,300,800,000.On average, 9 Wall Street analysts forecast DXCM's revenue for 2025 to be $1,812,168,695,173, with the lowest DXCM revenue forecast at $1,808,659,297,707, and the highest DXCM revenue forecast at $1,817,247,498,010. On average, 9 Wall Street analysts forecast DXCM's revenue for 2026 to be $2,095,854,206,029, with the lowest DXCM revenue forecast at $2,066,736,677,603, and the highest DXCM revenue forecast at $2,147,952,032,985.
In 2027, DXCM is forecast to generate $2,378,159,330,353 in revenue, with the lowest revenue forecast at $2,259,041,776,454 and the highest revenue forecast at $2,440,382,214,095.